Mechanism of interleukin-1β-induced calcitonin gene-related peptide production from dorsal root ganglion neurons of neonatal rats

Journal of Neuroscience Research

Volumn 73, Issue 2, 2003, Pages 188-197

  Hou, Lingfei ^a   Li, Wenjing ^a   Wang, Xian ^a,b  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Calcitonin gene related peptide; Dorsal root ganglion; Interleukin 1

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; DACTINOMYCIN; ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE C INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; FEMALE; GENE EXPRESSION; HEMODYNAMICS; MALE; MUSCLE SPINDLE AFFERENT NERVE; NERVE CELL CULTURE; NEUROGENIC INFLAMMATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; RIBONUCLEASE PROTECTION ASSAY; SENSORY NERVE CELL; SPINAL GANGLION; TIME;

ANIMALS; ANIMALS, NEWBORN; CALCITONIN GENE-RELATED PEPTIDE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GANGLIA, SPINAL; INTERLEUKIN-1; MALE; NEURONS; RATS; RATS, WISTAR;

EID: 0037829343     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10651     Document Type: Article

References (56)

1. Alvarez FJ, Kavookjian AM, Light AR. 1993. Ultrastructural morphology, synaptic relationships, and CGRP immunoreactivity of physiologically identified C-fiber terminals in the monkey spinal cord. J Comp Neurol 329:472-490.
2. Amara SG, Jonas V, Rosenfeld MG. 1982. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298:240-244.
3. Amara SG, Arriza JL, Leff SE, Swanson LW, Evans RM, Rosenfeld MG. 1985. Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science 229:1094-1097.
4. Beglinger C, Born W, Münch R, Kurtz A, Gutazwiller JP, Jäger K, Fischer JA. 1991. Distinct hemodynamic and gastric effects of human CGRP I and II in man. Peptides 12:1347-1351.
5. Bianchi M, Dib B, Panerai AE. 1998. Interleukin-1 and nociception in the rat. J Neurosci Res 53:645-650.
6. Brain SD, MacIntyre I, Williams TJ. 1986. A second form of human calcitonin gene-related peptide which is a potent vasodilator. Eur J Pharmacol 124:349-352.
7. Buckley TL, Brain SD, Collins PD, Williams TJ. 1991a. Inflammatory edema induced by interactions between IL-1 and the neuropeptide calcitonin gene-related peptide. J Immunol 146:3424-3430.
8. Buckley TL, Brain SD, Rampart M, Williams TJ. 1991b. Time-dependent synergistic interactions between the vasodilator neuropeptide, calcitonin gene-related peptide (CGRP) and mediators of inflammation. Br J Pharmacol 103:1515-1519.
9. Coimbra CR, Plourde V. 1996. Abdominal surgery-induced inhibition of gastric emptying is mediated in part by interleukin-1 beta. Am J Physiol 270:R556-R560.
10. Copray JCVM, Mantingh I, Brouwer N, Biber K, Küst BM, Liem RSB, Huitinga I, Tilders FJH, Van Dam AM, Boddeke HWGM. 2001. Expression of interleukin-1 beta in rat dorsal root ganglia. J Neuroimmunol 118:203-211.
11. Cruwys SC, Kidd BL, Mapp PI, Walsh DA, Blake DR. 1992. The effect of calcitonin gene-related peptide on formation of intra-articular oedema by inflammatory mediators. Br J Pharmacol 107:116-119.
12. Cunningham ET, De Souza EB. 1993. Interleukin-1 receptors in the brain and endocrine tissues. Immunol Today 14:171-176.
13. Dumoulin FL. 1991. Differential regulation of calcitonin gene-related peptide (CGRP) in regenerating rat facial nucleus and dorsal root ganglion. Eur J Neurosci 3:338-342.
14. Dumoulin FL, Raivich G, Haas CA, Lazar P, Reddington M, Streit WJ, Kreutzberg GW. 1992. Calctonin gene-related peptide and peripheral nerve regeneration. Ann N Y Acad Sci 657:351-360.
15. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC. 1990. Primary structure and function expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341-346.
16. Ferreira SH, Lorenzetti BB, Bristow AF, Poole S. 1998. Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334:698-700.
17. Follenfant RL, Nakamura-Craig M, Henderson B, Higgs GA. 1989. Inhibition by neuropeptides of ineterleukin-1β-induced, prostaglandin-independent hyperalgesia. Br J Pharmacol 98:41-43.
18. Fukuoka H, Kawatani M, Hisamitsu T, Takeshige C. 1994. Cutaneous hyperalgesia induced by peripheral injection of interleukin-1β in the rat. Brain Res 657:133-140.
19. Galeazza MT, Garry MG, Yost HJ, Strait KA, Hargreaves KM, Seybold VS. 1995. Plasticity in the synthesis and storage of substance P and calciconin gene-related peptide in primary afferent neurons during peripheral inflammation. Neuroscience 66:443-458.
20. Hanesch U, Pfrommer U, Grubb BD, Schaible HG. 1993. Acute and chronic phases of unilateral inflammation in rat's ankle are associated with an increase in the proportion of calcitonin gene-related peptide-immunoreactive dorsal root ganglion cells. Eur J Neurosci 19:2945-2953.
21. Herbert MK, Holzer P. 1994. Interleukin-1β enhances capsaicin-induced neurogenic vasodilatation in the rat skin. Br J Pharmacol 111:681-686.
22. Holman JJ, Craig RK, Marshall I. 1986. Human α- and β-CGRP and rat α-CGRP ate coronary vasodilators in the rat. Peptides 7:231-235.
23. Holzer P. 1988. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptide. Neuroscience 24:739-768.
24. i elevation in DRG neurons of neonatal rats. J Neurosci Res 66:592-600.
25. Hua XY, Chen P, Fox A, Myers RR. 1996. Involvement of cytokines in lipopolysaccharide-induced facilitation of CGRP release from capsaicin-sensitive nerves in the trachea: studies with interleukin-1beta and tumor necrosis factor-alpha. J Neurosci 16:4742-4748.
26. Ju G, Hökfelt T, Brodin E, Fahrenkrug J, Fisher JA, Prey P, Eld RP, Brown JC. 1987. Primary sensory neurons of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, smoatostatin-, galanin-, vasoactive intestinal polypeptide- and cholecystokinin-immunoreactive ganglion cells. Cell Tissue Res 247:417-431.
27. Kai-Kai MA. 1989. Cytochemistry of the trigeminal and dorsal root ganglia and spinal cord of the rat. Comp Biochem Physiol 93:183-193.
28. Kar S, Rees RG, Quirion R. 1994. Altered calcitonin gene-related peptide, substance P and enkephalin immunoreactivities and receptor binding sites in the dorsal horn of the polyarthritic rat. Eur J Neurosci 6:345-354.
29. Kawamura N, Tamura H, Obana S, Wenner M, Ishikawa T, Nakata A, Yamamoto H. 1998. Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation 5:9-15.
30. Lee Y, Takami K, Kawai Y, Girgis S, Hillyard CJ, MacIntyre I, Emson PC, Tohyama M. 1985. Distribution of calcitonin gene-related peptide in the rat peripheral nervous system with reference to its coexistence with substance P. Neuroscience 15:1227-1235.
31. Mulderry PK, Ghatel MA, Spokes RA, Jones PM, Pierson AM, Hamid QA, Kanse S, Amara SG, Burrin JM, Legon S, Polak JM, Bloom SR. 1988. Differential expression of α-CGRP and β-CGRP by primary sensory neurons and enteric automomic neurons of the rat. Neuroscience 23:195-205.
32. Noguchi K, Senba E, Morita Y, Sato M, Tohyama M. 1990a. Coexpression of α-CGRP and β-CGRP mRNAs in the rat dorsal root ganglion cells. Neurosci Lett 108:1-5.
33. Noguchi K, Senba E, Morita Y, Sato M, Tohyama M. 1990b. α-CGRP and β-CGRP mRNAs are differentially regulated in the rat spinal cord and dorsal root ganglion. Brain Res Mol Brain Res 7;299-304.
34. Oka T, Oka K, Hosoi M, Hori T. 1996. Inhibition of peripheral IL-1β-induced hyperalgisia by the intracerebroventricular admistration of diclofenac and α-melanocyte-stimulating hormone. Brain Res 736:237-242.
35. Oku R, Satoh M, Fyjii N, Otaka A, Yajima H, Takagi H. 1987. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal root horn in rats. Brain Res 403:350-354.
36. Oprée A, Kress M. 2000. Involvement of the proinflammatory cytokines tumor necrosis factor-α, IL-1β, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J Neurosci 20:6289-6293.
37. Perretti M, Ahluwalia A, Flower RJ, Manzini S. 1993. Endogenous tachykinins play a role in IL-1-induced neutrophil accumulation: involvement of NK-1 receptors. Immunology 80:73-77.
38. Ribeiro-da-Silva A. 1995. Ultrastructure features of the colocalization of calcitonin gene related peptide with substance P or somatostatin in the dorsal horn of the spinal cord. Can J Physiol Pharmacol 73:940-944.
39. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM. 1983. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304:129-135.
40. Russo AF, Nelson C, Roos BA, Rosenfeld MG. 1988. Differential regulation of the coexpressed calcitonin/α-CGRP and β-CGRP neuroendocrine genes. J Biol Chem 263:5-8.
41. Sacco NA, Filkins JP. 1988. Phagocytes and monokines: perspectives on metabolic regulation in sepsis. Magnesium 7:5-6.
42. Sarasa M, Terrado J, Mengod G, Climent S, Muniesa P, Palacinos JM. 1996. Differential expression of alpha-CGRP and beta-CGRP genes within hypoglossal motoneurons in response to axotomy. Brain Res Mol Brain Res 35:269-277.
43. Seybold VS, Galeazza MT, Hargeaves KM. 1995. Plasticity of calcitonin gene related peptide neurotransmission in the spinal cord during peripheral inflammation. Can J Physiol Pharmacol 73:1007-1014.
44. Skofitsch G, Jacobowitaz DM. 1985. Calcitonin gene-related peptide; detailed immunohistochemical distribution in the central nervous system. Peptide 6:721-745.
45. Steenbergh PH, Hoppener JWM, Zandberg J, Lips CJM, Jansz HS. 1985. A second human calcitonin/CGRP gene. FEBS Lett 183:403-407.
46. Sternini CK, Anderson K. 1992. Calcitonin gene-related peptide containing neurons supplying the rat digestive system differential distribution and expression pattern. Somatosens Mot Res 9:45-59.
47. Tang Y, Han C, Fiscus RR, Wang X. 1997. Increase of calcitonin gene-related peptide (CGRP) release and mRNA levels in endotoxic rats. Shock 7:225-229.
48. Wang X, Han CD, Fiscus RR, Qi M, Jones SB. 1991. Hypotension- and endotoxin-induced alterations in calcitonin gene-related peptide: modulation by dexamethasone. Circ Shock 34:217-223.
49. Wang X, Jones SB, Zhou Z, Han C, Fiscus RR. 1992. Calcitonin gene-related peptide (CGRP) and neuropeptide Y (NPY) levels are elevated in plasma and decreased in vena cava during endotoxin shock in the rat. Circ Shock 36:21-30.
50. Watkins LR, Maier SFM, Goehler LE. 1995. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63:289-302.
51. Watkins LR, Wiertelak EP, Goehler LE, Smity KP, Martin D, Maier SF. 1994. Characterization of cytokine-induced hyperalgesia. Brain Res 654:15-26.
52. Weihe E. 1990. Neuropeptide in primary afferent neurons. In: Zenker W, Neuhuber W, editors. The primary afferent neuron. New York: Plenum. p 127-159.
53. Weihe E, Nohr D, Millan MJ, Stein C, Miller S, Gramsch C, Herz A. 1988. Peptide neuroanatomy of adjuvant-induced arthritic inflammation in rat. Agents Actions 25:255-259.
54. Wiesenfeld-Hallin Z, Hökfelt T, Lundberg JM, Forssmann WG, Reinecke M, Tschopp FA, Fischer JA. 1984. Immunoreactive calcitonin gene-related peptide and substance P coexist in sensory neurons to the spinal cord and interact in spinal behavioral responses of the rat. Neurosci Lett 52:199-204.
55. Wimalawansa SJ. 1996. Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathphysiology, and therapeutic potentials. Endocrine Rev 17:533-585.
56. Yabuuchi K, Nishiyori A, Minami M, Satoh M. 1996. Biphasic effects of intracerebroventricular interleukin-1β on mechanical nociception in the rat. Eur J Pharmacol 300:59-65.